|

TCR-T cells targeting MAGE-A4 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1: 1

Top Sponsors

  • Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1

Indications

  • Advanced Mesenchymal Malignancies1
  • Cancer1

Other1 trial

Exploratory Clinical Study of TCR-T for MAGE-A4-positive Mesenchymal Malignancies
Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.